Publications by Dr Stuart McCracken - ePrints

Browsing publications by Dr Stuart McCracken.

Newcastle Authors	Title	Year
Dr Stuart McCracken Jonathan Aning Vincent Gnanapragasam	MRI-based nomogram for the prediction of prostate cancer diagnosis: A multi-centre validated patient–physician decision tool	2023
Dr Stuart McCracken Dr Tobias Page	Re-evaluating the diagnostic efficacy of PSA as a referral test to detect clinically significant prostate cancer in contemporary MRI-based image-guided biopsy pathways	2023
Dr Beth Adamson Nicholas Brittain Dr Laura Walker Ruaridh Duncan Dr Sara Luzzi et al.	The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer	2023
Dr Beth Adamson Nicholas Brittain Dr Laura Walker Ruaridh Duncan Dr Sara Luzzi et al.	The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer	2023
Dr Stuart McCracken	Assessment of Return to Baseline Urinary and Sexual Function Following Primary Focal Cryotherapy for Nonmetastatic Prostate Cancer	2021
Dr Stuart McCracken	Feasibility of Comparative Health Research Outcome of Novel Surgery in prostate cancer (IP4-CHRONOS): statistical analysis plan for the randomised feasibility phase of the CHRONOS study	2021
Dr Stuart McCracken Professor Damian Greene	Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study	2021
Dr Stuart McCracken	Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS): A prospective, multi-centre therapeutic phase II parallel Randomised Control Trial	2020
Alex Bainbridge Dr Scott Walker Joseph Smith Yi Min Ng Ng Huw Thomas et al.	IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway	2020
Evangelia Kounatidou Dr Sirintra Nakjang Dr Stuart McCracken Professor Craig Robson Dr Dominic Jones et al.	A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities	2019
Dr Stuart McCracken	Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry	2019
Dr Urszula McClurg Svitlana Korolchuk Dr Stuart McCracken Professor Rakesh Heer Laura Wilson et al.	Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein	2018
Dr Urszula McClurg Dr Mahsa Azizyan Dr Sirintra Nakjang Dr Stuart McCracken Professor Craig Robson et al.	Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12	2018
Dr Urszula McClurg Dr Sirintra Nakjang Dr Stuart McCracken Professor Craig Robson	A novel anti-androgen candidate galeterone acts by targeting USP12, a deubiquitinating enzyme that controls prostate cancer growth and survival	2016
Dr Urszula McClurg Victoria Harle Dr Scott Walker Dr Kelly Coffey Dr Luke Gaughan et al.	Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancer	2015
Dr Stuart McCracken Professor Rakesh Heer	Penile strangulation by a substantial metal napkin ring: successful removal with medtronic midas rex® legend® stylus® drill system	2013
Dr Stuart McCracken Dr Kanagasabai Sahadevan Professor Hing Leung	SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis	2012
Dr Stuart McCracken	ERK5 signalling in prostate cancer promotes an invasive phenotype	2011
Dr Luke Gaughan Dr Stuart McCracken Professor Craig Robson Dr Steven Powell	FUS/TLS Is a Novel Mediator of Androgen-Dependent Cell-Cycle Progression and Prostate Cancer Growth	2011
Dr Luke Gaughan Dr Jacqueline Stockley Nan Wang Dr Stuart McCracken Dr Kelly Coffey et al.	Regulation of the androgen receptor by SET9-mediated methylation	2011
Dr Stuart McCracken Garrett Durkan Rob Pickard Professor Craig Robson	Diagnosis and management of prostate cancer in the older man	2010
Professor Hing Leung Dr Arthur Mckie Dr Stuart McCracken Dr Helen Maitland Dr Sharon Olijslagers et al.	Loss of Sprouty2 Drives an Invasive Phenotype in Prostate Cancer and May Co-operate with HER2/3 in a Subgroup with Aggressive Disease	2009
Dr Stuart McCracken Professor Rakesh Heer Dr Marie Mathers Benjamin Jenkins Professor Craig Robson et al.	Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer	2008
Dr Stuart McCracken Professor David Neal Professor Hing Leung	Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer	2007
Dr Ian Logan Dr Luke Gaughan Dr Stuart McCracken Dr Vasileia Sapountzi Professor Hing Leung et al.	Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer	2006
Bharat Gowardhan David Douglas Dr Marie Mathers Dr Arthur Mckie Dr Stuart McCracken et al.	Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer	2005
Dr Stuart McCracken Benjamin Jenkins Professor Rakesh Heer Dr Marie Mathers Professor Craig Robson et al.	Expression analysis of the MEK5/ERK5 signalling pathway in human prostate cancer	2005
Dr Luke Gaughan Professor Craig Robson Dr Stuart McCracken Professor David Neal	Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors	2005